Inflammation-induced preterm birth alters neuronal morphology in the mouse fetal brain.
Adverse neurological outcome is a major cause of long-term morbidity in ex-preterm children. To investigate the effect of parturition and inflammation on the fetal brain, we utilized two in vivo mouse models of preterm birth. To mimic the most common human scenario of preterm birth, we used a mouse model of intrauterine inflammation by intrauterine infusion of lipopolysaccharide (LPS). To investigate the effect of parturition on the immature fetal brain, in the absence of inflammation, we used a non-infectious model of preterm birth by administering RU486. Pro-inflammatory cytokines (IL-10, IL-1beta, IL-6 and TNF-alpha) in amniotic fluid and inflammatory biomarkers in maternal serum and amniotic fluid were compared between the two models using ELISA. Pro-inflammatory cytokine expression was evaluated in the whole fetal brains from the two models. Primary neuronal cultures from the fetal cortex were established from the different models and controls in order to compare the neuronal morphology. Only the intrauterine inflammation model resulted in an elevation of inflammatory biomarkers in the maternal serum and amniotic fluid. Exposure to inflammation-induced preterm birth, but not non-infectious preterm birth, also resulted in an increase in cytokine mRNA in whole fetal brain and in disrupted fetal neuronal morphology. In particular, Microtubule-associated protein 2 (MAP2) staining was decreased and the number of dendrites was reduced (P < 0.001, ANOVA between groups). These results suggest that inflammation-induced preterm birth and not the process of preterm birth may result in neuroinflammation and alter fetal neuronal morphology.
Maternal and Child Health Research Program, Department of Obstetrics and Gynecology, Center for Research on Reproduction and Women's Health, University of Pennsylvania, Philadelphia, PA 19104-6142, USA. BurdI@obgyn.upenn.edu
Irina
I
Burd
Amy I
AI
Bentz
Jinghua
J
Chai
Juan
J
Gonzalez
Hubert
H
Monnerie
Peter D
PD
Le Roux
Akiva S
AS
Cohen
Marc
M
Yudkoff
Michal A
MA
Elovitz
D000653:Amniotic Fluid / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000196:embryology* / Q000378:metabolism / Q000473:pathology*; D002470:Cell Survival; D002478:Cells, Cultured; D016207:Cytokines / Q000378:metabolism; D004195:Disease Models, Animal; D005260:Female; D018836:Inflammation Mediators; D008070:Lipopolysaccharides; D051379:Mice; D015735:Mifepristone; D009474:Neurons / Q000473:pathology*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000097:blood; D047928:Premature Birth / Q000139:chemically induced / Q000276:immunology* / Q000473:pathology*; D012333:RNA, Messenger / Q000378:metabolism
D016207:Cytokines; D018836:Inflammation Mediators; D008070:Lipopolysaccharides; D012333:RNA, Messenger; D015735:Mifepristone